Evidence map›Paper›PMID 38449888›Full record

ArticleFrontiers in medicine2024

Corrigendum: Sex differences in the genetics of sarcoidosis across European and African ancestry populations.

Ying Xiong, Susanna Kullberg, Lori Garman, Nathan Pezant, David Ellinghaus, Vasiliki Vasila, Anders Eklund, Benjamin A Rybicki, Michael C Iannuzzi, Stefan Schreiber and 5 more

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Ying XiongRespiratory Medicine Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Susanna KullbergRespiratory Medicine Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Lori GarmanGenes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Nathan PezantGenes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
David EllinghausInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Vasiliki VasilaRespiratory Medicine Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Anders EklundDepartment of Respiratory Medicine and Allergy, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden.
Benjamin A RybickiDepartment of Public Health Sciences, Henry Ford Health System, Detroit, MI, United States.
Michael C IannuzziZucker School of Medicine, Staten Island University Hospital, Northwell/Hofstra University, Staten Island, NY, United States.
Stefan SchreiberInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Joachim Müller-QuernheimDepartment of Pneumology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Courtney G MontgomeryGenes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Johan GrunewaldRespiratory Medicine Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Leonid PadyukovCenter for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Natalia V RiveraRespiratory Medicine Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI JUDITH A JAMES · 2013 to 2026
$68.2M
Studies of Rare Genetic Variation in the Isolated Population of SardiniaR01HL117626 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABECASIS, GONCALO · 2013 to 2016
$10.5M
Rare variants and NHLBI traits in deeply phenotyped cohortsR01HL120393 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M, RICE, KENNETH M. · 2014 to 2016
$8.9M
Comprehensive Genome Interrogation of African American Sarcoidosis FamiliesR01HL113326 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI MONTGOMERY, COURTNEY · 2012 to 2022
$8.7M
Quantitative Analysis Core P30GM110766 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2014 to 2018
$6.1M
Rare variants and NHLBI traits in deeply phenotyped cohortsU01HL120393 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M, RICE, KENNETH M. · 2017 to 2018
$5.6M
NHLBI NIH HHS HHSN268201800001CNHLBI NIH HHS R01 HL113326NHLBI NIH HHS R01 HL117626NHLBI NIH HHS R01 HL120393NHLBI NIH HHS U01 HL120393NIEHS NIH HHS HHSN268201600032CNIGMS NIH HHS P30 GM110766NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fmed.2023.1132799.].

Indexed as

geneticsgenome-wide association study (GWAS)immunogenetics and HLAmeta-analysissarcoidosissingle nucleotide polymorphisms

Identifiers

PMID38449888
PMCPMC10915398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.